Efficacy of sofosbuvir, velpatasvir, and GS-9857 in patients with HCV genotype 2, 3, 4, or 6 infections in an open-label, phase 2 trial

Gastroenterology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2beRafO
via IFTTT